Q2 Earnings Estimate for ELVN Issued By Lifesci Capital
Enliven Therapeutics, Inc. (NASDAQ:ELVN – Free Report) – Analysts at Lifesci Capital issued their Q2 2025 earnings estimates for Enliven Therapeutics in a note issued to investors on Thursday, May 29th. Lifesci Capital analyst S. Slutsky forecasts that the company will earn ($0.54) per share for the quarter. The consensus estimate for Enliven Therapeutics’ current […]
Enliven Therapeutics, Inc. (NASDAQ:ELVN – Free Report) – Analysts at Lifesci Capital issued their Q2 2025 earnings estimates for Enliven Therapeutics in a note issued to investors on Thursday, May 29th. Lifesci Capital analyst S. Slutsky forecasts that the company will earn ($0.54) per share for the quarter. The consensus estimate for Enliven Therapeutics’ current […]
